COVID Vaccine Side Effects on the Kidney: What to Know

Kidney-related side effects after COVID-19 vaccination are real but rare, and the risk pales in comparison to the kidney damage COVID-19 infection itself can cause. A large cohort study found that the 30-day risk of acute kidney injury after vaccination was under 1%, while after COVID-19 infection it was nearly 5%, making the infection roughly seven to ten times more dangerous to the kidneys than the vaccine.¹ That said, a systematic review catalogued over 130 reported cases of kidney problems following vaccination, ranging from new-onset disease to flares of pre-existing conditions, and the variety of kidney disorders involved is worth understanding.²

How the Kidney Risk From Vaccination Compares to Infection

The most useful framing for this topic is relative risk, because the virus itself is a major kidney threat. In a study of nearly three million vaccinated individuals and more than three and a half million people who caught COVID-19, the absolute 30-day rate of acute kidney injury was about 0.66% after vaccination compared to about 4.88% after infection. After adjusting for age, sex, prior kidney history, and other health conditions, COVID-19 infection carried roughly ten times the risk of acute kidney injury compared to vaccination.³ The timing differed too: kidney injury after vaccination showed up on average about 13 days later, while after infection it appeared within about three and a half days, suggesting the mechanisms are not identical.¹

None of this means the vaccine’s kidney risk is zero, or that individual cases don’t matter. But it does mean that skipping vaccination to “protect” your kidneys likely does the opposite, since catching the virus exposes those same kidneys to a substantially larger threat.

What Kinds of Kidney Problems Have Been Reported

The kidney is not a single-function organ, and the reported side effects reflect that complexity. A systematic review of 90 published articles identified 130 cases of kidney adverse reactions, with about 70% being new-onset disease and about 30% being relapses of conditions patients already had. The most common diagnosis by far was minimal change disease, accounting for roughly 41% of cases. IgA nephropathy was second at about 38%, followed by a type of blood vessel inflammation called ANCA-associated vasculitis and acute interstitial nephritis.² The median age of affected patients was 42, and men were slightly more often affected than women.

These diagnoses can be loosely grouped into three categories: problems with the kidney’s filtering units (glomerular diseases), inflammation of the tissue between those filters (tubulointerstitial disease), and sudden drops in overall kidney function from muscle breakdown or other causes. Each presents differently and has different implications for recovery.

Minimal Change Disease

Minimal change disease is a condition where the kidney’s tiny filters suddenly start leaking large amounts of protein into the urine, leading to swelling throughout the body. Under a microscope, the kidney tissue looks nearly normal, which is where the name comes from. Multiple case reports have documented this appearing within days to weeks of COVID-19 vaccination. One case involved a man in his 30s with no prior kidney problems who developed progressive swelling over two weeks after his first dose of the Moderna vaccine. His urine protein was massively elevated, and a kidney biopsy confirmed minimal change disease.⁴ Another case involved a 75-year-old man who developed rapid, severe swelling and heavy protein loss after his second dose of the Pfizer vaccine.⁵

Minimal change disease is the most treatable of the conditions on this list. It typically responds well to steroids, and most reported post-vaccination cases followed this pattern. The condition is already known to be triggered by immune activation from infections and other vaccines, so the COVID-19 vaccine doing the same thing fits a recognized pattern rather than representing something entirely new.

IgA Nephropathy

IgA nephropathy, sometimes called Berger’s disease, happens when a specific type of antibody (IgA) deposits in the kidney’s filters, causing inflammation and blood in the urine. A review of 48 biopsy-confirmed cases found that about two-thirds were newly diagnosed, while the remaining third were relapses of existing disease. Most patients developed symptoms after their second dose, with a median onset of just two days. Among those who developed symptoms after their first dose, the onset was slower, with a median of about ten days.⁶

The rapid onset after the second dose is interesting. It suggests the immune system was already primed by the first dose, and the booster triggered a stronger immune response that spilled over into IgA production. IgA nephropathy flares have long been associated with respiratory infections and other vaccines, so physicians who manage this disease were already watching for it. For people with a known history of IgA nephropathy, this doesn’t necessarily mean avoiding vaccination, but it does mean being alert for visible blood in the urine or sudden swelling in the days and weeks afterward.

ANCA-Associated Vasculitis

ANCA-associated vasculitis is a more serious condition where the immune system attacks small blood vessels, often in the kidneys. Several case reports documented this appearing after COVID-19 vaccination. In one case, a patient developed kidney-limited disease with elevated antibodies against an enzyme called myeloperoxidase. A kidney biopsy showed a pattern of inflammation and tissue death in the glomeruli consistent with ANCA vasculitis.⁷ Another case showed a similar picture with significant scarring and crescent-shaped formations in the kidney filters, diagnosed after no other cause could be identified.⁸

ANCA vasculitis is a condition that requires aggressive treatment, typically with strong immune-suppressing drugs and sometimes plasma exchange. Unlike minimal change disease, the kidney damage can be permanent if treatment is delayed. The reported cases after vaccination remained very rare, but they underline the importance of seeking medical attention quickly if you develop dark or bloody urine, unexplained fatigue, or joint pain in the weeks after vaccination.

Membranous Nephropathy

Membranous nephropathy involves thickening of the walls of the kidney’s tiny filters, which leads to protein leaking into the urine. Both new-onset and relapsed cases have been reported after COVID-19 vaccination, generally appearing within about two weeks of the second dose.⁹ In one case, a kidney biopsy confirmed membranous nephropathy alongside signs of acute interstitial nephritis, and staining suggested the primary form of the disease rather than one caused by an outside trigger.¹⁰

Membranous nephropathy can sometimes resolve on its own, but it can also progress to chronic kidney disease if untreated. The fact that some cases tested positive for a specific antibody marker (PLA2R) is notable because that marker usually points to a primary autoimmune process rather than a direct toxic effect of any drug or substance.¹¹ The vaccine may have jolted the immune system into targeting the kidney’s own tissue, rather than the vaccine itself directly harming the organ.

Acute Interstitial Nephritis

Acute interstitial nephritis is inflammation of the tissue surrounding the kidney’s tubules, the structures that fine-tune what stays in your blood and what ends up in your urine. A panoramic review identified 36 patients diagnosed with this condition after COVID-19 vaccination, nearly all confirmed by kidney biopsy and all first-time diagnoses.¹² Cases have appeared across age groups, including a 12-year-old girl who developed non-oliguric acute kidney injury six days after her second Pfizer dose, confirmed by biopsy as severe acute tubulointerstitial nephritis.¹³

The good news is that this condition tends to respond well to corticosteroids. In one well-documented case, a patient received oral prednisolone after biopsy confirmation, and kidney function steadily improved over the following months. The steroids were tapered and eventually stopped about four months after diagnosis, and the patient continued to recover without needing additional immune-suppressing drugs.¹⁴ Another case showed similar improvement with high-dose prednisolone, reinforcing the general pattern that early recognition and treatment lead to good outcomes.¹⁵

Rhabdomyolysis and Kidney Failure

Rhabdomyolysis is not a kidney disease per se, but it can wreck the kidneys. It happens when muscle tissue breaks down and releases a protein called myoglobin into the bloodstream, which clogs and damages the kidney’s filtering tubes. Several cases of rhabdomyolysis have been reported after COVID-19 vaccination. One patient developed rhabdomyolysis with extremely high creatine kinase levels just one day after his second Pfizer dose. While his muscle weakness eventually resolved with intravenous fluids, his kidney function did not recover, and he remained dependent on dialysis after discharge.¹⁶

In the most severe documented case, rhabdomyolysis after COVID-19 vaccination was fatal, and the authors noted that autoimmune factors appeared to play a role.¹⁷ Rhabdomyolysis is a recognized complication of many vaccines and medications, but the COVID-19 cases have drawn attention because some progressed rapidly to kidney failure. If you develop severe muscle pain, dark urine, or extreme weakness after vaccination, these symptoms warrant urgent medical evaluation.

Thrombotic Microangiopathy

Thrombotic microangiopathy is a condition where tiny blood clots form in the smallest vessels of the kidney, damaging the delicate structures that filter blood. One case report documented this after the Pfizer vaccine, with biopsy showing a blood clot lodged in the kidney’s filter, extensive damage to the basement membrane, and injury to the cells lining the blood vessels.¹⁸

For people who already have a condition predisposing them to this kind of clotting, the numbers are more informative. A study of 27 patients with atypical hemolytic uremic syndrome or complement-mediated thrombotic microangiopathy found that COVID-19 infection triggered episodes at a much higher rate than vaccination: about 23% of infections triggered a flare, compared to roughly 1% of vaccinations.¹⁹ This echoes the broader theme: even among people at heightened risk of vaccine-related kidney problems, the virus itself is typically more dangerous to the kidneys than the vaccine.

Why the Vaccine Might Trigger Kidney Problems

Proving that the vaccine directly causes a given kidney problem in a specific patient is difficult because many of these conditions occur spontaneously in the general population. In a case series of five patients who developed biopsy-confirmed kidney diseases after vaccination, including IgA nephropathy, minimal change disease, thrombotic microangiopathy, and acute tubulointerstitial nephritis, the authors explicitly noted that “the specific pathophysiologic link and causality between the incidence of kidney diseases and COVID-19 vaccination are difficult to confirm.”²⁰

The leading hypothesis involves the immune system’s response going beyond what was intended. COVID-19 vaccines work by exposing the body to parts of the virus’s spike protein, which provokes an immune response. In rare cases, that response may cross-react with the body’s own tissues through a process where proteins on the spike protein happen to resemble proteins on kidney cells. The immune system, geared up to attack the spike protein, accidentally targets these similar-looking kidney structures as well. A second proposed mechanism involves nonspecific activation of immune pathways unrelated to the spike protein itself.²¹ Both mechanisms could explain why the range of kidney conditions is so varied: the immune system is misfiring in different ways in different people, depending on their genetic background and immune makeup.

Do Different Vaccine Types Carry Different Risks

Most of the reported kidney problems have followed mRNA vaccines (Pfizer and Moderna), but that largely reflects the fact that mRNA vaccines were administered far more widely. The raw numbers suggest adenovirus-vector vaccines (like AstraZeneca and Johnson & Johnson) may carry a slightly higher per-dose rate of acute kidney injury. In one large cohort, about 0.6% of mRNA vaccine recipients experienced an acute kidney injury event, compared to about 0.9% of those who received viral vector vaccines.¹

A separate study from Taiwan found that both the BioNTech and Moderna mRNA vaccines were associated with a higher risk of developing acute kidney injury and needing dialysis compared to unvaccinated individuals.²² Interpreting these comparisons is tricky because the people who chose different vaccines often differed in age, health status, and other factors that independently affect kidney risk. No head-to-head randomized trial has compared kidney outcomes across vaccine platforms, so the current data is suggestive rather than definitive about which platform carries more or less kidney risk.

Kidney Transplant Recipients

People who have received a kidney transplant take medications to suppress their immune system so the body doesn’t reject the new organ. Vaccination stimulates the immune system, which raises an obvious question: could the vaccine wake up the rejection machinery? One case report documented acute humoral and cellular rejection of a transplanted kidney 14 days after an adenovirus-vector vaccine. The patient’s new kidney failed entirely and they required dialysis.²³

However, a larger study looking at 45 solid organ transplant recipients who experienced rejection events after mRNA vaccination found a median delay of about 102 days between vaccination and rejection. The rejections were scattered continuously across time with no identifiable clustering, which argues against the vaccine being the direct cause. The researchers concluded that the pattern was “not in favor of a role of vaccination in rejection.”²⁴ Rejection episodes happen in transplant patients regardless of vaccination, and without controlled comparisons it is hard to know whether the rate was actually elevated. Major transplant organizations have continued to recommend COVID-19 vaccination for transplant recipients, judging that the risk from infection outweighs the theoretical risk of triggering rejection.

Warning Signs and When to Seek Help

The kidney does not produce pain the way a pulled muscle does, so kidney problems after vaccination can sneak up on you. The symptoms to watch for depend on which type of kidney issue is developing, but there is overlap:

Foamy urine: bubbles that persist after flushing suggest protein leaking into the urine, which is the hallmark of glomerular diseases like minimal change disease or membranous nephropathy.
Bloody or dark urine: visible blood or cola-colored urine points toward IgA nephropathy or ANCA vasculitis and warrants same-day medical evaluation.
Swelling: puffiness around the eyes, ankles, or legs that develops over days to weeks after vaccination can signal heavy protein loss.
Reduced urine output: producing notably less urine than usual, especially alongside any of the above symptoms.
Severe muscle pain with dark urine: this combination suggests rhabdomyolysis and needs emergency evaluation, since the window to prevent permanent kidney damage is narrow.

Most of these symptoms would appear within the first few weeks after vaccination. The fact that the median onset of kidney injury after vaccination was about 13 days suggests that the highest-risk window extends roughly two to three weeks after each dose. If you have a pre-existing kidney condition or a history of autoimmune disease, your nephrologist may want to check bloodwork and urine protein levels a few weeks after vaccination as a precaution.

How Kidney Problems After Vaccination Are Treated

Treatment depends entirely on the specific diagnosis, which almost always requires a kidney biopsy. For the most common post-vaccination kidney problem, minimal change disease, corticosteroids are the standard first-line treatment and most patients respond well. Acute interstitial nephritis follows a similar playbook: steroids, often tapered over several months, with the expectation that kidney function will recover. For ANCA-associated vasculitis, the treatment is more aggressive, typically involving a combination of steroids and stronger immune-suppressing drugs, because delay risks permanent kidney scarring. Rhabdomyolysis is treated with aggressive intravenous fluid hydration, though some patients still progress to chronic dialysis despite treatment.

The general trajectory for most post-vaccination kidney problems is recovery, particularly when the diagnosis is made promptly. This is one area where the medical literature is cautiously encouraging: the majority of reported cases saw improvement with appropriate treatment. But “most recover” is not the same as “all recover,” and a handful of cases, particularly rhabdomyolysis and severe vasculitis, resulted in permanent kidney damage or death. The rarity of these outcomes needs to be weighed against the much larger number of people vaccinated without any kidney issues at all.

People With Existing Kidney Disease

If you already have chronic kidney disease or a condition like IgA nephropathy or lupus nephritis, the question of whether to get vaccinated involves balancing two competing risks. On one hand, you are in a group more vulnerable to the kidney effects of both the vaccine and the virus. On the other hand, COVID-19 infection poses a dramatically higher kidney risk than the vaccine does, and people with chronic kidney disease are already at elevated risk for severe COVID-19 outcomes. The ten-fold difference in acute kidney injury risk between vaccination and infection holds across multiple subgroups in the available data.¹

For people with a history of glomerular disease that has relapsed after other immune triggers, a reasonable strategy is to coordinate vaccination timing with your nephrologist, ensure your disease is in stable remission beforehand, and schedule follow-up lab work a few weeks after each dose. This is not because vaccination is contraindicated, but because early detection of a flare allows for early treatment, which dramatically improves outcomes.

1
npj Vaccines. Assessing acute kidney injury risk after COVID vaccination and infection in a large cohort study
2
PubMed Central. Renal Side Effects of COVID-19 Vaccination
3
PubMed Central. Assessing acute kidney injury risk after COVID vaccination and infection in a large cohort study – Section: Abstract
4
PubMed Central. New-onset minimal change disease following the Moderna COVID-19 vaccine
5
PubMed Central. Minimal change disease soon after Pfizer-BioNTech COVID-19 vaccination
6
PubMed Central. New-onset IgA nephropathy following COVID-19 vaccination
7
PubMed Central. ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine
8
PubMed Central. Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Renal Vasculitis Following COVID-19 Vaccination: A Case Report and Literature Review
9
PubMed Central. New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 Vaccination
10
PubMed Central. A Case of Membranous Nephropathy Hypothesized to be Associated With COVID-19 Vaccine
11
PubMed Central. De novo PLA2R positive membranous nephropathy following BNT162b2 mRNA COVID-19 vaccine
12
PubMed Central. New-Onset Acute Interstitial Nephritis Post-SARS-CoV-2 Infection and COVID-19 Vaccination: A Panoramic Review
13
PubMed Central. Acute tubulointerstitial nephritis after the second dose of the Pfizer COVID-19 vaccine
14
BMJ Case Reports. Acute interstitial nephritis after COVID-19 vaccination
15
PubMed Central. Acute interstitial nephritis with acute kidney injury after COVID-19 vaccination: a case report
16
PubMed Central. Rhabdomyolysis after COVID-19 Comirnaty Vaccination: A Case Report
17
PubMed Central. Fatal Case of Rhabdomyolysis Post-COVID-19 Vaccine
18
PubMed Central. Acute Kidney Injury Following Vaccine-Induced Thrombotic Microangiopathy
19
PubMed Central. Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination
20
PubMed Central. New-Onset Kidney Diseases after COVID-19 Vaccination: A Case Series
21
PubMed Central. SARS-CoV-2 vaccine-triggered autoimmunity: Molecular mimicry and/or bystander activation of the immune system
22
PubMed Central. Risk of acute kidney injury and mortality in patients vaccinated against COVID-19
23
PubMed Central. Acute kidney rejection after anti-SARS-CoV-2 virus-vectored vaccine-case report
24
PubMed. Timing of rejection events preceded by Covid-19 mRNA vaccination in recipients of solid organ transplants